LinkedIn founder and venture capitalist Reid Hoffman has just launched drug discovery startup Manas AI, alongside Dr.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

This new approach, based on natural selection, dramatically improves the reliability of large language models for practical ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

$540 $319 for your first year Make up your own mind. Build robust opinions on the FT's trusted journalism. Offer available ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

The Chinese firm has pulled back the curtain to expose how the top labs may be building their next-generation models. Now ...

The order, signed in October 2023, required companies building powerful AI systems to share their safety test results with the federal government and come up with ways to limit their models’ biases ...

For a slew of AI chip companies chomping to dethrone Nvidia, DeepSeek is the opening they’ve been waiting for.

The persistent challenge of AI hallucinations - where artificial intelligence systems generate false or misleading ...

But China isn’t standing still. The country is already looking beyond DeepSeek, with plans to integrate AI into emerging technologies like 6G networks, autonomous vehicles, and smart cities. By 2030, ...